Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li>Shares of Windlas Biotech listed at ₹439 while the price band was fixed at ₹448-460 per share.</li><li>The IPO was subscribed 22.56 times on the last day of the bidding.</li><li>The market capitalisation of the company stood at ₹956.77 crore.</li></ul>Shares of Windlas Biotech made a weak listing on the National Stock Exchange (NSE) and BSE as the stock listed at 4.5% discount over the issue price band of ₹448-460 apiece. Post listing, the market capitalisation of the company stood at ₹956.77 crore, according to BSE data. The shares of Windlas Biotech were trading at ₹436, lower by 5.2% at 10.07 a.m., on August 16. However, the grey market had indicated an 18-20% premium for the stock a few days prior to the listing. The IPO ⁠— open between August 4 and August 6 ⁠— saw decent demand from investors. It was subscribed 22.56 times on the last day of the bidding. The Uttarakhand-based company is a pharmaceutical formulations contract development and manufacturing organisation (CDMO). It provides pharmaceutical development services and large-scale manufacturing services. The offer comprises ₹165 crore of fresh issue and offer for sale upto 51.42 lakh shares. The company will utilise the proceeds from the IPO towards purchase of equipments required for capacity expansion of existing facility at Dehradun Plant IV, addition of injectables dosage capability at its existing facility at Dehradun Plant II (₹50 crore), working capital requirements (₹47.5 crore), repayment of debt of ₹20 crore and for general corporate purposes. “Windlas is one of the leaders in the domestic pharmaceutical formulations contract development and manufacturing organisation (CDMO) industry. We believe the company is well placed to grab the opportunity arising from the industry given its strong product portfolio, relationship with its customers, research and development capabilities and efficient &amp; quality compliant manufacturing facilities...We have a positive view on the company from the long term perspective,” said analysts at Religare Broking firm. SEE ASLO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/krsnaa-diagnostics-ipo-list-at-7-premium-only/articleshow/85360735.cms">Shares of Krsnaa Diagnostics gets a tepid reception at the bourses, list at 7% premium</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/shares-of-exxaro-tiles-listed-at-a-premium-of-5-compared-to-its-issue-price-of-120/articleshow/85360810.cms">Exxaro Tiles shares debut at a 5% premium as the vitrified tiles maker posts a lukewarm listing on stock exchanges</a>

Windlas Biotech IPO makes a weak stock market debut; list at 4.5% discount on exchanges

<ul><li>Windlas Biotech is likely to announce its share allotment status on August 11.</li><li>The company provides pharmaceutical development services and large-scale manufacturing services.</li><li>The IPO of the company was subscribed 22.56 times on the last day of bidding.</li></ul>Windlas Biotech is likely to announce the allotment status of its initial public offering (IPO) on August 11. The IPO was open for subscription from August 4 to August 6 with a price band of ₹448-460. The company is looking to raise ₹402 crore on its upper price band. The company is a pharmaceutical formulations contract development and manufacturing organisation (CDMO). It provides pharmaceutical development services and large-scale manufacturing services. The IPO has received a good response from qualified institutional buyers and retail investors. The portion reserved for qualified institutional investors was subscribed 24.1 times while that for retail investors was subscribed 24.54 times. Here is how to <keyword id="11833554" type="UNKNOWN" weightage="20" keywordseo="windlas-biotech-ipo-allotment">Windlas Biotech IPO allotment</keyword> status on stock exchange website: <ul><li>Go to the <a href="https://www.bseindia.com/investors/appli_check.aspx">BSE website</a> or NSE website<a href="https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp"> here</a>.</li><li>On BSE, Select 'Equity' and then from the dropdown, select 'Windlas Biotech’.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'.</li><li>Please note the details will only be available once the shares are allotted.</li></ul>You can also visit the registrar website (Link Intime India) to check your application status. <ul><li>Visit the registrar's website <a href="https://linkintime.co.in/MIPO/Ipoallotment.html">here</a>.</li><li>Click on 'Select company' and click on 'Windlas Biotech’.</li><li>Once the company is selected, you will have to enter either your PAN detail, the application number, or the client ID.</li><li>Enter the captcha and click ’submit’. </li></ul>Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/cryptocurrency/news/crypto-firm-mudrex-which-offers-mutual-fund-like-crypto-investment-tools-raises-2-5-million-in-a-seed-round/articleshow/85205115.cms">This Indian crypto company just raised $2.5 million to launch crypto mutual funds and ETFs</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/mukesh-ambanis-reliance-industries-may-bid-for-deutsche-telekom-ags-netherlands-subsidiary-reports-bloomberg/articleshow/85212874.cms">Mukesh Ambani's Reliance Industries may bid for Deutsche Telekom AG's Netherlands subsidiary, reports Bloomberg</a>

Here’s how to check Windlas Biotech IPO allotment status, listing date and more

<ul><li><keyword id="11265795" type="UNKNOWN" weightage="20" keywordseo="Windlas-Biotech-IPO">Windlas Biotech IPO</keyword> opens on August 4 and closes on August 6.</li><li>Demat account, trading application and UPI ID are mandatory if you are applying for an initial public offering (IPO).</li><li><keyword id="11265796" type="UNKNOWN" weightage="20" keywordseo="Windlas-Biotech">Windlas Biotech</keyword> is looking to raise over ₹402 crore at the upper price band of ₹460.</li></ul>Another initial public offering (IPO) coming up this week is of Windlas Biotech. The company is a pharmaceutical formulations contract development and manufacturing organisation (CDMO). It provides pharmaceutical development services and large-scale manufacturing services. Windlas Biotech IPO has a price band of ₹448-460 and the company is looking to raise ₹402 crore on its upper price band. Here is a guide on how to apply in IPOs easily. Firstly, to invest in an IPOs, you need to apply to buy a ‘lot of shares’ from the market. The bidding for these IPOs is usually open for three days particularly during market hours. For Windlas Biotech IPO the bidding will open on August 4 and close on August 6. A Demat account, a trading application like Zerodha, Angel Broking etc and UPI ID on BHIM app are necessary if you want to invest conveniently in an IPO. Unified payment interface (UPI) is a banking system for money transfers on payment apps like Google Pay, PhonePe and so on. One of the simplest ways to track IPOs and invest in them is through trading platforms. Here’s how you can do it through Zerodha’s Kite application, which is meant for trading stocks and commodities. <ul><li>Login to the mobile app and select the IPO option under the console. If you’re logging in through desktop, then go to console -- portfolio -- IPO.</li><li>You will find a list of IPOs that are open for investment. Select the IPO you want to invest in.</li><li>Enter your UPI ID from the BHIM app. Ensure your UPI ID is mapped to your personal bank account.</li><li>Enter the lot size (number of shares required to buy in one lot) announced by the company.</li><li>Tick on the cut off price for more chances of allotment of shares as it indicates investor’s willingness to subscribe to shares at any price discovered within the price band. Cut off price is the issue price.</li><li>Retail investors can bid for a maximum of three lots.</li><li>After this step, click on the check box to confirm and submit.</li><li>The last step is to accept the mandate request for proceeding with IPO on your BHIM UPI app. Once you accept the mandate, the amount of funds for IPO will be blocked till the allotment.</li><li>Now wait till the allotment date of shares to see if you have received the lot size you bid for.</li></ul>If you have invested through broking firm like Upstox, here are the 5 simple steps to invest in an IPO: Step 1: Login to the Upstox application or website with your credentials. Step 2: Select the IPO that you want to invest in and create an IPO application. Step 3: Add up to 3 bids within the price range. Step 4: Confirm your application. Step 5: Accept the UPI mandate and block funds on your mobile UPI app Another way to invest is through your bank. This option is generally available between 5 a.m. and 11 a.m. on the bank’s website. Here’s how to do it: <ul><li>Log in to your bank’s net banking account.</li><li>Go to the investment section and select the IPO option.</li><li>Fill your investment and bank account details to complete the verification process.</li><li>Later select the IPO you want to apply for.</li><li>Enter the number of shares and bid price.</li><li>Read and accept ‘terms and conditions’ documents.</li><li>Submit your application.</li></ul>SEE ALSO: <a href="https://www.businessinsider.in/business/startups/news/travel-portal-ixigo-moves-a-step-closer-to-ipo/articleshow/85006033.cms">Travel portal Ixigo moves a step closer to IPO </a><a href="https://www.businessinsider.in/stock-market/news/heres-why-nifty-broke-the-16000-barrier/articleshow/85004061.cms">Here’s why Nifty broke the 16,000 barrier ⁠— Titan, HDFC, Nestle and Ultratech tell the story of the euphoria in the Indian stock market</a><a href="https://www.businessinsider.in/stock-market/news/heres-why-nifty-broke-the-16000-barrier/articleshow/85004061.cms"></a><a href="https://www.businessinsider.in/stock-market/news/heres-why-nifty-broke-the-16000-barrier/articleshow/85004061.cms"></a><a href="https://www.businessinsider.in/stock-market/news/heres-why-nifty-broke-the-16000-barrier/articleshow/85004061.cms"></a><a href="https://www.businessinsider.in/stock-market/news/heres-why-nifty-broke-the-16000-barrier/articleshow/85004061.cms"></a><a href="https://www.businessinsider.in/stock-market/news/heres-why-nifty-broke-the-16000-barrier/articleshow/85004061.cms"></a>

Windlas Biotech IPO open today: Here’s how to apply via banks and apps like Zerodha, Upstox

<ul class="summary-list"><li><keyword id="279743" type="COMPANY" weightage="60" keywordseo="Krispy-Kreme">Krispy Kreme</keyword> jumped as much as 11.7% during its first day of trading. </li><li>The doughnut shop priced its <keyword id="6354763" type="UNKNOWN" weightage="60" keywordseo="ipo">IPO</keyword> below the expected range.</li><li>The company's first day of trading pales in comparison to other IPOs this week that saw pops above 68%.</li></ul><a href="https://markets.businessinsider.com/stock/DNUT">Krispy Kreme</a> climbed as much as 11.7% to $19.00 per share during its trading debut on Thursday.The doughnut shop franchise opened at $16.30, lower than its IPO price, but then pared back losses. Shares were trading around $18.50 as of Wednesday 1:05 p.m. ET. Krispy Kreme raised $500 million by offering 29.4 million shares at $17, below the expected range of $21-$24. The company offered 2.7 million more shares than anticipated. At pricing, the company commanded a fully diluted market value of $2.9 billion.That valuation was likely too high, according to David Trainer, CEO of investment research firm New Constructs."We think the stock is worth no more than $1.6 billion, which is slightly higher than the $1.35 billion JAB Holdings paid to take Krispy Kreme private in 2016. With this IPO, we believe JAB Holdings is looking to cash out at the expense of new investors," Trainer said in a recent note. The analyst said that Krispy Kreme faces obstacles such as competition from larger food incumbents like Wendy's and a shift in consumer preferences toward healthier foods. "Dough-Not buy this overpriced IPO" was the title of his research report. Krispy Kreme is one of 18 companies to hit the <keyword id="31671" type="CITY" weightage="100" keywordseo="markets">markets</keyword> this week in the busiest week for IPOs since December 2004. So far, its stock hasn't popped as high as others. Alzheimer's biotech company Acumen Pharmaceuticals soared 68.4% on Thursday during its IPO. On Wednesday, <a href="https://markets.businessinsider.com/news/stocks/didi-stock-price-ipo-chinese-firm-alibaba-ride-hailing-2021-6-1030568810">Didi jumped as much as 28%</a> in its first day of trading, while shares of <a href="https://markets.businessinsider.com/stocks/lz-stock?utm_source=markets&amp;utm_medium=ingestgest" target="_blank" rel="noopener">LegalZoom</a> popped as much as 39% in their <a href="https://markets.businessinsider.com/news/stocks/legalzoom-stock-price-ipo-debut-lz-7-billion-valuation-2021-6-1030568686">debut</a> and cybersecurity company SentinelOne surged as much as 30%. There have been 215 IPOs priced this year, a +225.8% change from the same date last year, per Renaissance Capital. J.P. Morgan, Morgan Stanley, BofA Securities, Citi, BNP Paribas, Deutsche Bank, Evercore ISI, Goldman Sachs, HSBC, Truist Securities, and Wells Fargo Securities acted as joint bookrunners on the Krispy Kreme deal.

Krispy Kreme climbs 11% in public debut during the busiest IPO week since 2004

<ul><li>Windlas Biotech is all set to launch its initial public offering (IPO) in the first week of August.</li><li>The company provides pharmaceutical development services and large-scale manufacturing services.</li><li>It is looking to raise <keyword id="11746985" type="UNKNOWN" weightage="20" keywordseo="402">₹402</keyword> crore at the upper price band of ₹460.</li></ul>Windlas Biotech has announced to come up with its initial public offering (IPO) on August 4 with a price band of ₹448-460. The company is looking to raise ₹402 crore on its upper price band. The company is a pharmaceutical formulations contract development and manufacturing organisation (<keyword id="253890" type="ORGANIZATION" weightage="20" keywordseo="CDMO">CDMO</keyword>). It provides pharmaceutical development services and large-scale manufacturing services. The offer comprises ₹165 crore of fresh issue and offer for sale upto 51.42 lakh. Here are the important details to note: <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Issue details </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;"> </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Price band </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹448 to ₹460 </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO open date </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 4 </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO close date </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 6 </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Allotment date </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 11 </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Initiation of refunds </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 12 </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Credit of shares to demat account </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 13 </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO listing date </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 17 </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Minimum lot </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">30 </td></tr></tbody></table>Source: Company release Currently, the company has 4 manufacturing facilities located at Dehradun in Uttarakhand. Proceeds from the IPO will be utilised in purchase of equipments required for capacity expansion of existing facility at <keyword id="11746983" type="UNKNOWN" weightage="20" keywordseo="dehradun-plant-iv">Dehradun Plant IV</keyword>, addition of injectables dosage capability at its existing facility at <keyword id="11746984" type="UNKNOWN" weightage="20" keywordseo="dehradun-plant-ii">Dehradun Plant II</keyword> (₹50 crore), working capital requirements (₹47.5 crore), repayment of debt of ₹20 crore and for general corporate purposes. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Particulars </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">FY21 </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">FY20 </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">FY19 </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Profits </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹15.5 crore </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹16.2 crore </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹63.8 crore </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Revenue </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹427.6 crore </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹328.8 crore </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹307.2 crore </td></tr><tr><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Total borrowings </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹31.3 crore </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹27.4 crore </td><td style="border-left:solid #000000 0.9375pt;border-right:solid #000000 0.9375pt;border-bottom:solid #000000 0.9375pt;border-top:solid #000000 0.9375pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹29.9 crore </td></tr></tbody></table> SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/list-of-stocks-are-down-today-like-zomato-dixon-technologies-cdsl-happiest-minds-shree-renuka-sugars-and-more/slidelist/84817104.cms">It's not just Zomato — From Happiest Minds to CDSL, some of India's hottest stocks are melting too </a> <a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms">Hindalco market value crosses 1 lakh crore as share price surges </a> <a href="https://www.businessinsider.in/stock-market/news/list-of-stocks-are-down-today-like-zomato-dixon-technologies-cdsl-happiest-minds-shree-renuka-sugars-and-more/slidelist/84817104.cms"></a><a href="https://www.businessinsider.in/stock-market/news/list-of-stocks-are-down-today-like-zomato-dixon-technologies-cdsl-happiest-minds-shree-renuka-sugars-and-more/slidelist/84817104.cms"></a><a href="https://www.businessinsider.in/stock-market/news/list-of-stocks-are-down-today-like-zomato-dixon-technologies-cdsl-happiest-minds-shree-renuka-sugars-and-more/slidelist/84817104.cms"></a><a href="https://www.businessinsider.in/stock-market/news/list-of-stocks-are-down-today-like-zomato-dixon-technologies-cdsl-happiest-minds-shree-renuka-sugars-and-more/slidelist/84817104.cms"></a><a href="https://www.businessinsider.in/stock-market/news/list-of-stocks-are-down-today-like-zomato-dixon-technologies-cdsl-happiest-minds-shree-renuka-sugars-and-more/slidelist/84817104.cms"> </a><a href="https://www.businessinsider.in/stock-market/news/list-of-stocks-are-down-today-like-zomato-dixon-technologies-cdsl-happiest-minds-shree-renuka-sugars-and-more/slidelist/84817104.cms"></a><a href="https://www.businessinsider.in/stock-market/news/list-of-stocks-are-down-today-like-zomato-dixon-technologies-cdsl-happiest-minds-shree-renuka-sugars-and-more/slidelist/84817104.cms"></a><a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms"></a><a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms"></a><a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms"></a><a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms"></a><a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms"></a><a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms"></a><a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms"></a><a href="https://www.businessinsider.in/stock-market/news/hindalco-market-value-crosses-1-lakh-crore-as-share-price-surges/articleshow/84851388.cms"></a>

Windlas Biotech to raise ₹395-402 crore through public listing, price band fixed at ₹448-460

<ul><li><keyword id="8830896" type="UNKNOWN" weightage="20" keywordseo="Rossari-Biotech">Rossari Biotech</keyword> listed at ₹677.10 on the bourses, with an upside of 59% </li><li>The Mumbai-based speciality chemical maker, Rossari Biotech’s IPO, was subscribed 79 times, with non-institutional investors leading the charge.</li><li>The IPO was issued at a price band of ₹425.</li></ul>The ₹496 crore IPO of Rossari Biotech had a bumper listing today. The stock added nearly 16.4% in a few hours of its listing debut. The IPO was issued at a price band of ₹425, but it listed at ₹677.10, with an upside of 59% <div type="image" title="Copy of Rossari (1)" msid="77124535" hostid="261"></div> Its market cap rose to ₹3,981 crore. A total traded quantity of 18.36 lakh shares changed hands on BSE amounting to a turnover of ₹128.14 crore. The Mumbai-based speciality chemical maker, Rossari Biotech’s IPO, was subscribed 79 times, with non-institutional investors leading the charge, oversubscribing by almost 240 times. Non-institutional investors are those who bid more than ₹2 lakh in an IPO. The reason behind the bumper listing is the company's wide variety of customers ranging from FMCG and apparel to poultry and animal feed industries to companies that make home and personal care products. Some of the significant customers include HUL, Panasonic India, RSPL Ltd, IFB Industries Ltd. and Millennium Papers. <div type="Youtube" id="F5N4v_XPbR0" title="Rossari Biotech is hiring ⁠— and the company’s average salary is ₹10 lakh per year" thumbUrl="https://i.ytimg.com/vi/F5N4v_XPbR0/mqdefault.jpg"></div> SEE ALSO:<a href="https://www.businessinsider.in/business/corporates/news/asian-paints-share-price-this-may-be-the-worst-summer-for-sales-and-profit/articleshow/77119613.cms" data-type="tilCustomLink"> Shareholders await Asian Paints’ account of a lost summer</a> <a href="https://www.businessinsider.in/finance/banks/news/indian-public-sector-bank-employees-get-15-wage-hike-and-performance-linked-incentives-after-three-years-of-waiting/articleshow/77114388.cms" data-type="tilCustomLink">Indian public sector bank employees get 15% wage hike and performance-linked incentives after three years of waiting</a>

Stellar listing for Rossari Biotech - stock price surges over 16% on listing day

<ul><li><keyword id="3519758" type="PERSON" weightage="20" keywordseo="route-mobile">Route Mobile</keyword> made a strong debut on the bourses on Monday, surging 105% over its initial public offer (IPO) price.</li><li>Route Mobile issued the IPO at a price band of ₹350, but it listed at ₹717 apiece. </li><li>Route Mobile’s total market cap rose to ₹3,980 crore at 10:05 am.</li></ul>The cloud communication platform services provider, Route Mobile, made a strong debut on the bourses on Monday, surging 105% over its initial public offer (IPO) price. The company had garnered a stellar response from investors in its ₹600-crore IPO, which closed on September 11 with a whopping oversubscription of 73.30 times. Investors who applied for the IPO are being rewarded with hefty gains. Route Mobile issued the IPO at a price band of ₹350, but it listed at ₹717 apiece, with an upside of 105%. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Top IPOs this year </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Listing gains </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Happiest Minds Technologies Ltd </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">138% </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Rossari Biotech Ltd </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">65% </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">SBI Cards and Payment Services Ltd </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-12% </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Mindspace Business Parks </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">10.55% </td></tr></tbody></table> However, the weakness in the market weighed on the shares and it was trading 9% lower at ₹646 a piece at 10:12 am. <div type="image" title="Route Mobile" msid="78227918" hostid="261"></div> Route Mobile’s total market cap rose to ₹3,980 crore at 10:05 am. A total traded quantity of 10.31 lakh shares changed hands on BSE amounting to a turnover of ₹73.76 crore. The company will trade with the symbol of ‘ROUTE’ on the Indian stock exchanges. The bumper listing was already on the cards! After a strong debut of Happiest Minds Tech last week, Route Mobile was already expected to witness stellar listing. Its monopoly in the sector is something that makes the company stand out in the IPO rush. Ahead of its IPO, the company had already raised ₹180 crore from 15 anchor investors, including Goldman Sachs, Franklin Templeton Mutual Fund, and SBI Life Insurance, Kuwait Investment Authority, Vantage Equity Fund, and SBI Life Insurance, among others. SEE ALSO: <a href="https://www.businessinsider.in/business/telecom/news/airtel-seems-to-be-sticking-to-its-strengths-while-its-shareholders-want-jio-like-fireworks/articleshow/78222570.cms" data-type="tilCustomLink">Airtel seems to be sticking to its strengths while its shareholders want Jio-like fireworks</a> <a href="https://www.businessinsider.in/stock-market/news/top-stocks-to-watch-future-group-stocks-irctc-rites-sbi-bank-of-india-pnb-and-more/articleshow/78226309.cms" data-type="tilCustomLink">Top stocks to watch— Future Group stocks, IRCTC, RITES, SBI, Bank of India, PNB and more</a>

You Searched For "windlas biotech ipo stock debut" and got 7 results

Windlas Biotech IPO makes a weak stock market debut; list at 4.5% discount on exchanges

Bhakti Makwana

Here’s how to check Windlas Biotech IPO allotment status, listing date and more

Bhakti Makwana

Windlas Biotech IPO open today: Here’s how to apply via banks and apps like Zerodha, Upstox

Bhakti Makwana

Krispy Kreme climbs 11% in public debut during the busiest IPO week since 2004

Emily Graffeo

Windlas Biotech to raise ₹395-402 crore through public listing, price band fixed at ₹448-460

Bhakti Makwana

Stellar listing for Rossari Biotech - stock price surges over 16% on listing day

Navdeep Yadav

After Happiest Minds Tech, Route Mobile doubles the money invested in the IPO

Navdeep Yadav

Popular Keywords

Buying Guides